Forventes på lager: 30-04-2018
The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.
| Forlag | Springer International Publishing AG |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | Softcover reprint of the original 1st ed. 2016 |
| Udgivelsesdato | 30-04-2018 |
| Første udgivelsesår | 2018 |
| Serie | Resistance to Targeted Anti-Cancer Therapeutics |
| Illustrationer | 6 Illustrations, color; 2 Illustrations, black and white |
| Fagredaktør | Daniele Focosi |
| Originalsprog | Switzerland |
| Sideantal | 188 |
| Indbinding | Paperback / softback |
| Forlag | Springer International Publishing AG |
| Sideoplysninger | 188 pages, 6 Illustrations, color; 2 Illustrations, black and white |
| Mål | 235 x 155 |
| ISBN-13 / EAN-13 | 9783319834382 |